Eligible Companies for Exchange

Centivo offers self-funded health plans designed to make healthcare more affordable for both employees and employers. The company allows employers to provide their workforce with user-friendly, cost-effective, and predictable healthcare options. Centivo enhances the member experience by providing a variety of benefit choices, including proprietary primary care-centered models and traditional networks. This enables self-funded employers to support the sustainable livelihoods of their employees.

Cerapedics, a developer of ortho-biological technology, is dedicated to offering bone graft substitutes for use in spinal fusion surgery and other orthopedic procedures. The company's technology centers on the creation and commercialization of innovative biologic products that integrate a small peptide as an attachment factor to catalyze the natural bone healing process. This empowers physicians to facilitate safer and more predictable bone formation compared to conventional bone growth factors available in the market.

Cerebral is a provider of online emotional health services aimed at assisting patients suffering from depression, anxiety, and insomnia. The company facilitates regular evaluations, video consultations, continuous care manager follow-ups, prescriptions, and medication delivery. This enhances the accessibility of treatment for anxiety and depression. Also, Cerebral assigns a care manager for routine check-in calls and messages, thereby helping patients to enhance their mental and emotional health.

Chapter delivers Medicare advisory services designed to enhance the way seniors select their health coverage. The company provides retirees with customized discounts and offers, tax guidance, news updates, and technology advice, empowering the elderly to age with confidence and purpose.

Chroma Medicine is advancing genomic medicines aimed at transforming the treatment of genetically influenced diseases. The company's innovative approach leverages epigenetics, the natural mechanism for regulating genes, by employing programmable epigenetic editors. These editors specifically target genes and manage chromatin structure by pairing a DNA binding domain with epigenetic effector domains. This enables healthcare professionals to utilize a new class of therapeutics, achieving unprecedented precision in controlling gene expression.

Cityblock operates a personalized health system designed to meet the unaddressed health and social needs of Medicaid and Medicare populations. The company offers an innovative model of integrated primary care, behavioral health, and social services that are delivered within the community. Cityblock also allies with community-based organizations, empowering clinicians to provide individualized care for each member.

Clarify is the creator of a real-time analytics and care guidance platform, which is designed to intertwine predictive analytics and machine learning into the fabric of care delivery models. Their innovative digital platform flawlessly merges robust analytics, artificial intelligence, real-time patient navigation, and intelligent workflows to actively guide patients and their caregivers along personalized care journeys. This enables care providers to offer healthcare of higher value.

Cleerly is a developer of a healthcare platform aimed at establishing a new standard of care for coronary artery disease. The company's platform employs a non-invasive method to enhance understanding of plaques, offering detailed quantification and characterization of plaque buildup in the heart's arteries. This enables healthcare providers to significantly enhance the identification of at-risk patients, facilitating early treatment and prevention of heart attacks in a cost-effective manner.

Clipboard Health operates a healthcare talent marketplace designed to offer healthcare staffing services. Its marketplace features an extensive database of nursing jobs, providing nursing and allied health staff across the nation. Clipboard Health also ensures ease of use for both healthcare facilities and professionals, thereby guaranteeing that patients receive the appropriate nurse at the right time for their medical needs.

Collective Health has developed a cloud-based self-insurance platform aimed at transforming the functionality of health benefits. This platform facilitates the integrated management of all health plans via a unified portal, providing straightforward guidance, real-time concierge support, and digital tools for locating and managing care. This enables the healthcare industry to seamlessly connect with medical, pharmacy, dental, and vision plans.

Color has developed a population care delivery device that aids in promoting sustainable and fair public health across all populations. The company provides health programs and partners with state public health departments to address healthcare logistics issues by consolidating all the essential abilities needed for healthcare delivery into a single proven model. This approach creates a variety of market opportunities and revenue sources. As a result, clinical teams are enabled to perform tasks such as testing, screening, treatment, and referrals more effectively.

Colossal Laboratories & Biosciences is a pioneering bioscience and genetic engineering firm devoted to innovating transformative technologies to revolutionize genomics. The company is dedicated to creating groundbreaking solutions for the restoration of extinct species, the protection of critically endangered species, and the repopulation of vital ecosystems necessary for the survival of life on Earth. Utilizing CRISPR technology, Colossal Laboratories & Biosciences aims to de-extinct species, starting with the woolly mammoth. This enables environmental organizations to rejuvenate Earth to a healthier state while also addressing the future economic and biological needs of the

Commure has developed an interoperable cloud-based platform dedicated to speeding up innovation in healthcare software. Its platform integrates various datasets, highlights significant insights, enhances performance via a collection of applications, and fosters smooth innovation throughout the healthcare sector. This platform allows clinicians and staff across different healthcare facilities to improve care through teamwork.

Conformal has developed a medical implant device aimed at preventing strokes in patients with atrial fibrillation. This innovative device is specifically designed for non-valvular atrial fibrillation and adapts to the unique anatomy of each patient, ensuring effective atrial appendage closure. By providing this tailored solution, Conformal enables doctors and medical professionals to effectively treat patients at risk of strokes, ultimately saving lives.

Convergent Therapeutics is a clinical-stage biotechnology company committed to harnessing the full potential of dual-targeted combination strategies for cancer treatment. The company has created a therapeutic platform that targets both validated and novel cancer antigens by utilizing targeting agents with varied bio-distributions, such as monoclonal antibodies, ligands, and supra-additive therapeutic doses. This approach enables healthcare providers to deliver effective cancer therapies to their patients.

Covera Health is the developer of a clinical intelligence platform designed to minimize medical misdiagnoses and enhance care quality. The company's solutions scrutinize clinical datasets to promote emerging science, focusing initially on radiology—where accurate and early diagnosis significantly influences a patient's care journey. By employing clinically validated, science-based tools, it aids physicians in improving their care, ensuring correct diagnoses for patients, and enabling the healthcare system to support quality enhancement on a large scale. This approach allows employers and payers to boost patient outcomes while reducing unnecessary healthcare expenditures.

Crossover is a healthcare platform operator that is designed to pinpoint and offer personalized care experience for a thriving and inspired workforce. The company's platform introduces a novel care delivery model for health-focused employers and combines isolated health and wellness benefits with tech-empowered services to enhance access to care, curtail spending and provide remarkable health for employees regardless of location. This enables clients to lessen healthcare expenses and expand employee access to medical services.

Delfi Diagnostics has developed a blood test system specifically designed for early cancer detection. The company's medical system utilizes machine learning to focus on the research and development of pioneering blood and genome testing to identify and intercept cancer at a curable stage. This technology allows healthcare professionals to discover previously unnoticed cancer-related cell-free DNA fragments and administer effective treatments for faster healing.

Detect develops an AI platform aimed at discovering biotechnology tools. This platform features an intelligent evolution engine that enhances molecular designs through AI and selects top performers using unique, parallel single-molecule technologies. Detect's innovation assists the biotechnology industry in creating the next generation of biosensors, gene-editing tools, and biomaterials.

Dewpoint Therapeutics is developing a healthcare technology aimed at identifying new drugs for a wide range of diseases. By leveraging a proprietary experimental and AI-powered platform, the company enhances drug discovery. Dewpoint Therapeutics utilizes machine-learning-based image analysis tools to visualize condensates and offers an engine comprising a collection of engineered cell lines with trackable condensates to prevent detrimental protein sequestration. The company has active programs in oncology, neurodegenerative, cardiopulmonary, and metabolic diseases, and collaborates with leading academic and pharmaceutical partners globally. This enables healthcare providers to access new therapies that address unmet medical

Dispatch Biotherapeutics is focused on creating cancer treatments that leverage the power of the immune system. The company is dedicated to developing therapies aimed at eradicating cancer tumors while preventing their recurrence, thereby offering patients more effective cancer treatment options.

DispatchHealth offers on-demand mobile and virtual healthcare services intended to provide top-notch and effective care. Their services comprise mobile units staffed with acute care clinicians and equipped with a Clinical Laboratory Improvement Amendments-certified lab, medical equipment, medications, IVs, and Wi-Fi connectivity. This enables patients to choose high-quality and affordable care for a wide range of diseases at their homes or workplaces.

DNAnexus, a developer of a biomedical informatics and data management platform, is designed to process DNA-sequencing data analysis. The platform supports researchers in various sectors including biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia to expedite their global genomics programs. This allows both commercial and academic medical researchers to visualize and analyze big data systems for DNA from a single, integrated system.

Egenesis is developing a gene editing and genome engineering platform aimed at revolutionizing solid organ and therapeutic cell transplantation for treating life-threatening illnesses. The company's platform provides gene editing techniques to create human-compatible organ tissue cells and spearheads programs in kidney and islet cell transplantation, allowing patients to recover and maintain a healthy life.

Eikon Therapeutics is a company that operates a platform for drug discovery and development, aiming to provide innovative treatments for life-threatening diseases. Their platform allows for the precise identification of compound-protein interactions that are typically unidentifiable through traditional assays. It achieves this by directly observing the impact of chemical compounds on the behavior of a wide range of individual proteins within a live cellular environment. This technology enables healthcare companies to leverage otherwise challenging protein classes as potential drug targets.

Elektrofi has developed a drug delivery platform aimed at enhancing subcutaneous administration. Their formulation system efficiently processes a wide range of therapeutic molecules, and their technology is capable of handling large, complex, and delicate proteins, such as monoclonal antibodies, as well as bispecific and fusion proteins. This enables drug manufacturers to create groundbreaking therapies with ease, empowering patients to have control over how they receive and benefit from transformative medicines.

Element Biosciences is a biotechnology company focused on developing innovative and affordable DNA sequencing technologies. Their platform aims to deliver high-quality genomic data with greater accuracy and flexibility, catering to a wide range of research and clinical applications. Element Biosciences seeks to democratize access to advanced sequencing capabilities, driving progress in genomics and personalized medicine.

Embark is the creator of a DNA testing kit intended to enhance dog health and wellness. The kit identifies genetic markers, equipping dog owners with crucial health data. It provides breed analysis, key insights into genetic disease susceptibility, and inheritable traits. This allows pet owners to discover their dog's breed, health, and potential diseases, all through a straightforward cheek swab.

Encoded Therapeutics is a developer of precise gene therapies, designed to offer treatments for a wide array of serious genetic conditions. The company's therapeutic pipeline tackles severe genetic and acquired disorders that span numerous disease pathways such as neurocircuitry, metabolic disorders, neurodegeneration, and heart disease. This allows healthcare professionals to treat patients and enhance their quality of life.

Endeavor BioMedicines, a clinical-stage organization, is dedicated to creating innovative therapies that target the root causes of pulmonary fibrosis. The company is researching a small-molecule inhibitor, which holds promise for the treatment of idiopathic pulmonary fibrosis (IPF). This inhibitor could potentially stop, and even reverse, the progression of IPF. Endeavor BioMedicines enables healthcare professionals to concentrate on precision treatments for terminal diseases, thereby improving patient well-being and longevity.

Engrail Therapeutics develops transformative medicines aimed at alleviating the significant impact of nervous system diseases. The company's solutions focus on improving the lives of patients with life-limiting neurological conditions by merging biological insights with effective clinical solutions. Engrail Therapeutics is committed to creating and advancing a diverse portfolio of groundbreaking treatments, simplifying complex disease therapies, and ultimately helping patients lessen their overall disease burden.

Enveda Biosciences has developed a drug analysis platform that leverages chemical diversity and evolutionary insights to accelerate the creation of superior medicines. This innovative platform integrates machine learning, metabolomics, and robotics to assess natural samples for chemical structures and their biological activities and functions. By eliminating the need to isolate individual compounds or conduct extensive experimentation, Enveda Biosciences enables healthcare clients to develop new antibiotics and hypotensives and to identify and characterize a diverse array of molecules produced by living organisms.

EQRx, a biotechnology firm, is dedicated to making medicines affordable for everyone. The company collects an extensive array of medicines across various disease areas, introduces late-stage cancer drugs to the market, and develops more cost-effective therapy combinations. This enables patients to have better access to medicines at a lower cost.

Equip operates a virtual eating disorder treatment program designed to help families recover from eating disorders in the comfort of their homes. The program provides a dedicated team, including a therapist, dietitian, medical doctor, peer mentor, and family mentor, who work together to support meeting eating goals. This approach allows patients to achieve recovery affordably at home.

Essence Healthcare provides a broad spectrum of healthcare services geared to aid healthcare service providers. Their plans encompass numerous services such as prescription drug coverage, dental, vision, and hearing services. They also offer access to fitness centers and complimentary transportation to medical appointments. This enables healthcare service providers to deliver high-quality, value-based care to their patients.

Everly Health is a provider of a digital healthcare platform designed to deliver contemporary diagnostic-driven care. The company provides a comprehensive at-home testing experience, backed by a nationwide network of clinicians, including doctors, nurses, genetic counselors, and member care specialists. This allows both consumers and businesses to enjoy convenient and extensive health testing services.

Evidation Health has developed a health data analytics platform that is designed to gather and evaluate continuous behavioral data and healthcare details. Evidation Health's platform transforms unrefined, high-frequency daily behavior data obtained from sensors, devices, speech, video, and other sources into beneficial insights concerning health and diseases. This allows individuals and companies to comprehend and influence the daily behaviors that contribute to improved health outcomes.

Exo is the creator of a handheld ultrasound gadget designed for therapeutic applications and medical imaging. The company's innovative technology integrates advanced nano-materials, state-of-the-art sensor technologies, sophisticated signal processing, and computation, all produced with the cost-effectiveness of semiconductor manufacturing. This enables healthcare professionals to make crucial, real-time decisions that enhance patient outcomes at a more affordable and convenient cost.

Firefly Health offers primary health care services designed to transform patient care and ensure it is accessible to everyone. By integrating technology with a dedicated care team, the company provides continuous, insightful care that encourages behavioral changes and delivers value. Firefly Health's virtual-first approach to primary care includes live video appointments with primary care physicians and a team dedicated to convenience, all without any membership fees. This enables customers to make informed health decisions while assisting clinicians in delivering consistent and proactive care.

Flare Therapeutics is a health-tech company focused on developing small-molecule precision medicines for cancer patients. Their platform is adept at targeting transcription factors to identify precision treatments for neurology, rare genetic disorders, immunology, and inflammation. This enables healthcare professionals to alter the course of disease treatment effectively.

Florence offers an electronic document workflow software aimed at simplifying and ensuring compliance for clinical trial documents. Their platform minimizes repetitive tasks for trial sites and automates site access, facilitating remote document monitoring. Additionally, it provides real-time insights into study progress, allowing clients to streamline trial operations and expedite research studies.

FogPharma specializes in creating cell-penetrating mini proteins (CPMPs) aimed at targeting and neutralizing cancer-causing proteins within cancer cells. These CPMPs represent a groundbreaking class of medicines capable of reaching drug targets that conventional therapies cannot address, allowing physicians to effectively treat diseases related to cancer.

Foresight Mental Health operates a clinic focused on mental health and wellness, providing diverse treatments and healthcare services. By transforming mental healthcare through its clinic network, the company provides patient profiles, a repository of scientific research, and analysis of crucial data including genetic profiles, detailed symptom assessments, and brain-chemical balance estimates, helping patients achieve greater happiness and health.

Found offers medically-guided weight-loss and maintenance programs designed to enhance an individual's overall well-being. The company's plans feature personalized nutrition and exercise programs, access to a dedicated health coach, and a supportive private community. Additionally, Found provides online consultations with board-certified practitioners to assess and incorporate medications for cellular-level weight management. This enables individuals to achieve weight loss and maintain a healthy lifestyle.

Freenome has developed a multi-omics platform that is designed to detect cancer at its early stages using a simple blood draw. The company's unique platform employs a proprietary algorithmic method that strives to revolutionize disease management through systematic early detection and intervention of disease screenings. This allows doctors to treat cancer and other diseases while they are still at manageable stages.

Frontier Medicines has developed a chemoproteomics platform aimed at speeding up the creation of new drugs. This platform combines computational techniques with machine learning to identify and target novel binding sites on proteins, making these sites accessible for small-molecule drug discovery and development. This innovation allows healthcare professionals to offer medications that can alter the trajectory of debilitating diseases, ultimately benefiting patients.

Galileo, a developer of a health support mobile app, aims to enhance the efficiency and affordability of healthcare. The company's app integrates technology with a human-centric design and features lab monitoring with specialty medications. This gives users the opportunity to connect with a team of expert clinicians from wherever they are, to maintain their health.

Generate Biomedicines has developed an innovative generative biology platform aimed at creating new drugs across various protein modalities and therapeutic areas. By utilizing machine learning, the company deciphers the genetic code that dictates protein function, allowing for the generation of antibodies, peptides, enzymes, as well as cell and gene therapies tailored to any therapeutic requirement. This enables researchers to deliver new medicinal solutions to patients effectively.